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Background: Offloading plantar pressure is a key strategy for the prevention or healing of neuropathic plantar
ulcers in diabetes. Non-removable walking casts, such as total contact casts, are currently considered the
gold-standard for offloading this type of wound. However, alternative methods for offloading that are more cost
effective and easier to use are continually being sought. The aim of this study was to evaluate the capacity of the
DH Pressure Relief Shoe™ to offload high pressure areas under the neuropathic foot in diabetes.
Methods: A within-subjects, repeated measures design was used. Sixteen participants with diabetic peripheral
neuropathy were recruited and three footwear conditions were evaluated in a randomised order: a canvas shoe
(the control), the participants’ own standard shoe, and the DH Pressure Relief Shoe™. The primary outcome was
peak plantar pressure, measured using the pedar-X® mobile in-shoe system between the three conditions.
Results: Data analysis was conducted on 14 out of the 16 participants because two participants could not
complete data collection. The mean peak pressure values in kPa (±SD) for each condition were: control shoe 315.9
(±140.7), participants’ standard shoe 273.0 (±127.1) and DH Pressure Relief Shoe™ 155.4 (±89.9). There was a
statistically significant difference in peak plantar pressure between the DH Pressure Relief Shoe™ compared to both
the control shoe (p = 0.002) and participants’ standard shoe (p = 0.001). The DH Pressure Relief Shoe™ decreased
plantar pressures by 51% compared to the control shoe and by 43% compared to participants’ standard shoe.
Importantly, for a couple of study participants, the DH Pressure Relief Shoe™ appeared unsuitable for day-to-day
wearing.
Conclusions: The DH Pressure Relief Shoe™ reduced plantar pressures more than the other two shoe conditions.
The DH Pressure Relief Shoe™ may be a useful alternative to current offloading modalities used in clinical
management of diabetic foot ulceration. However, clinical trials are needed to test their effectiveness for ulcer
healing and to ensure they are useable and safe for patients in everyday activities.Background
Foot ulceration in diabetes has been recognised as a
major medical, social and economic problem all over the
world [1]. This is not surprising given that approxi-
mately 15% of people with diabetes will develop a foot
ulcer in their lifetime and that resolution of foot ulcers
is often a lengthy and complex process [1]. The burden
foot ulceration places on health care systems globally is
substantial, with 85% of all diabetes-related amputations* Correspondence: a.raspovic@latrobe.edu.au
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reproduction in any medium, provided the orbeing preceded by a foot ulcer [2]. Significant adverse
psychological consequences may also result, including
diminished psychosocial adjustment to illness, altered
satisfaction with personal life, poorer health-related
quality of life and depression [3].
Localised tissue trauma, in the presence of clinically-
significant sensory neuropathy, is an important risk fac-
tor for chronic plantar foot ulceration in people with
diabetes [1]. Although, the complex role of biomechan-
ics in diabetes-related foot ulceration is not fully under-
stood, elevated dynamic peak plantar pressure is a
strong risk factor for future ulceration, particularly when
occurring in conjunction with loss of protectiveal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ing or reducing elevated peak plantar pressure is import-
ant for the successful management of plantar
neuropathic foot ulceration in diabetes. A robust body of
evidence supports this notion as illustrated by recent
high-quality reviews of the literature [5-7].
The salient clinical issue is not whether to use offload-
ing in the management of neuropathic ulceration, but
what type/s of offloading modality will achieve the best
result in light of the clinical situation and broader pa-
tient context. A wide range of offloading modalities are
currently available, with studies finding that the ability
of these devices to reduce pressure ranges from 20% to
80% when compared to a control [7]. However, a barrier
exists to evidence-based offloading practice due to there
being limited research and guidelines for offloading mo-
dalities, with the exception of total contact casts (TCCs)
and other irremovable cast walkers [5]. A study by Wu
et al. (2008) showed that the currently accepted gold
standard for offloading, the TCC [5,8], was being used
regularly by less than 2% of practitioners surveyed, suggest-
ing there are important barriers to the implementation
of best-practice offloading [9]. In some instances this
may be associated with issues such as lack of training
and limited experience with the application of TCCs. In
other cases it is likely that there are mitigating circum-
stances where offloading modalities such as TCCs may
not be suitable. Factors such as patient preference, clin-
ical presentation, mobility requirements and social
stigma may make use of TCC difficult. In cases where
TCCs and other irremovable cast walkers are not appro-
priate for use, selecting offloading modalities based on
evidence is challenging due to the paucity of research.
Alternative methods for off-loading that are effective,
economical, easy to use and have little impact on the
patient’s lifestyle are continually being sought. The DH
Pressure Relief ShoeTM is one such alternative, however to
the authors’ knowledge, evidence evaluating its effective-
ness at off-loading plantar pressure does not exist. The
aim of this study was to evaluate the capacity of the DH
Pressure Relief ShoeTM to offload high pressure areas
under the neuropathic foot in diabetes.Table 1 Participant characteristics (N = 14)
Characteristic Value
Age in years: mean ± SD (range) 65.4 ± 3.3 (48 to 81)
Gender (No.) 13 male : 1 female
Weight in kilograms: mean ± SD (range) 97.2 ± 15.5 (59 to 108)
Diabetes duration in years: mean ± SD (range) 22.7 ± 3.8 (3 to 48)
Previous ulceration 4 yes : 10 no
Note: two cases were excluded due to missing data (footwear issues),
therefore the final analysis was conducted on 14 participants.Methods
Participants
This study used a within-subject, repeated measures de-
sign. Approval was granted from two Institutional Ethics
Committees and informed consent was obtained from
all participants prior to their participation in the study.
Sixteen participants were recruited to the study, 15 male
and 1 female. This sample size was pre-specified and
was based on an 80% probability of detecting a clinically
meaningful difference between interventions of 100 kPain peak plantar pressure (standard deviation of 100 kPa
and alpha set at 0.05), using an appropriate formula[10].
Participants were recruited via advertisements and direct
approach from a local university podiatry clinic and a
hospital-based, outpatient high-risk foot service.
Participants were included if they were male or female
aged over 18 years and had either a history of, or active
plantar neuropathic ulceration. Those perceived at fu-
ture risk of ulceration were also eligible – risk of ulcer-
ation has been defined by Armstrong et al. as a
combination of a vibratory perception threshold >25 V
and monofilament testing of four imperceptible sites,
which has shown to be a highly sensitive and specific
method for detecting risk of ulceration [11]. Four parti-
cipants reported a past history of foot ulceration and
one of these participants presented with a current plan-
tar foot ulcer.
Participants were excluded from the study if they were
found to have active infection at the wound site, distin-
guished by the cardinal signs of warmth, redness, pain,
tenderness, induration and purulent exudate. Partici-
pants were also deemed ineligible if they required the
use of a walking aide, had current pain or injury unre-
lated to the ulceration that affected walking, had an
ulcer from other causes, had more than one digit ampu-
tated or were unable to speak basic English. Those with
acute Charcot’s neuroarthropathy, determined by the
clinical signs of unilateral swelling, elevated skin
temperature, erythema and joint effusion were also
excluded from participating in the study. The character-
istics of participants are shown in Table 1.
Footwear conditions
All participants were measured in the following three
footwear conditions:
(i) canvas footwear (Dunlop Volley, Pacific Dunlop
Ltd, Melbourne, Australia);
(ii) the participants’ own standard footwear;
(iii) the DH Pressure Relief ShoeTM, Royce Medical
(now the DH Offloading Post-op ShoeTM, Ossur, CA).
The canvas shoes (Figure 1) were selected as their
lightweight construction and flat, thin and flexible soles
Figure 1 Canvas Dunlop Volley™ (control) shoe.
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pressures across participants [12]. The participants’ own
standard footwear (Figure 2) consisted of the shoes the
participant wore most regularly and ranged from stand-
ard, extra-depth flat lace-up shoes to customised be-
spoke footwear. The purpose of this footwear condition
was to establish pressure offloading properties of standard
footwear to enable a direct comparison to the DH
Pressure Relief ShoeTM. If the participant wore insoles
or orthoses that were additional to any insoles that
came with the shoe, these were removed prior to
measurement.
The final shoe condition was the DH Pressure Relief
ShoeTM (Figures 3a and 3b), which is a relatively new off-
loading device designed for people with high pressure or
ulceration on the plantar surface of the foot. The DH
Pressure Relief ShoeTM is designed for short-term (one to
four months) use in the treatment of plantar wounds,
such as diabetes-related neuropathic ulceration. TheFigure 2 Example of a participant’s standard shoe.inside of the DH Pressure Relief ShoeTM consists of an
insole comprised of hexagonal-shaped plugs, made from
three layers that are a combination of mixed density
materials including PORON® (Figure 3b). The plugs are
15 mm thick and have a Velcro undersurface to keep
them firmly in place but enables their removal over the
areas of high pressure as required. The upper of the DH
Shoe is a soft synthetic fabric, which is fastened to the
foot with large Velcro straps (Figure 3a). For this study,
the plugs were removed either under the site of active or
previous plantar forefoot or midfoot neuropathic ulcer-
ation, or if the participant did not present with a history
of neuropathic ulceration, under the right 1st metatarso-
phalangeal joint, as this is widely accepted as one of the
most common sites for neuropathic ulceration [13].
Randomisation
To minimise potential ordering effects, the three footwear
conditions were tested using a random order sequence,
a. 
b. 
Figure 3 (a) DH Pressure Relief Shoe™ (b) Insole of DH Pressure Relief Shoe™ with hexagonal plugs removed from under the right first
metatarsophalangeal joint.
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investigators collecting the pressure data could not be
blinded to the testing condition that was being assessed
in respective trials. However, as the plantar pressure ap-
paratus produces objective data, the investigators
thought this would have minimal impact.Pressure measuring equipment
Plantar pressures were measured with the in-shoe pedar-
X® system (Novel GmbH, Munich, Germany), a reliable,
valid and accurate measure of in-shoe pressure [14,15].
The pedar-X® insoles are approximately 2 mm thick and
consist of 99 capacitive pressure sensors that are
arranged in a grid alignment. Plantar pressure data were
sampled at a frequency of 50 Hz. All insoles had been
calibrated with the trublu® calibration device prior tothe commencement of the study (Novel GmbH, Munich,
Germany).
Measurement protocol
The appropriately sized pedar-X® insole was placed in
each shoe condition (i.e. under the foot) for measure-
ment. Prior to the first walking trial of each condition,
the pressure insoles were zeroed as described by the
manufacturer’s guidelines (Novel GmbH, Munich, Ger-
many). After a familiarisation period of approximately
2 minutes, participants completed three walking trials
for each condition. Participants were timed as they
walked at a comfortable self-determined speed along a
10 m walkway. If a trial did not fall within 5% of the ori-
ginal walking time, it was eliminated and repeated to
minimise the effect of altered walking speed on plantar
pressures [16]. To exclude the effect of acceleration and
Raspovic et al. Journal of Foot and Ankle Research 2012, 5:25 Page 5 of 8
http://www.jfootankleres.com/content/5/1/25deceleration steps, only the middle steps from each trial
of the foot undergoing measurement were included for
analysis. An average recording was determined from ap-
proximately nine steps (i.e. three steps from three trials)
for each condition. In order to meet the independence
requirement for statistical analysis, data from only one
site on one foot was selected from each participant for
analysis [17].
Outcome measures
The primary outcome measure was peak plantar pres-
sure underneath the selected high pressure site, for each
condition. Peak pressure was chosen due to its import-
ance in indicating offloading effectiveness and thus clin-
ical utility. To evaluate if alterations in peak pressure
under the mask of interest (i.e. where the DH Pressure
Relief ShoeTM plugs were removed) might be attribut-
able to changes in weight bearing area of the plantar
surface of the foot, contact area between shoe condi-
tions was analysed as a secondary outcome. We also
measured contact time for the whole foot in order to
cross check consistency of walking speed.
Statistical analysis
The plantar pressure data were processed through the
Novel-win® program (version 20.3.30). A Novel mask
was applied to identify the nominated high pressure site,
which formed the primary area for comparison across
the three shoe conditions. Data for the variables peak
plantar pressure (within mask), contact area (whole foot)
and contact time (whole foot) were extracted for analysis
using the Statistical Package for the Social Sciences (SPSS)
Version 18.0 (SPSS Inc., Chicago, IL). The data were
explored for normality of distribution prior to inferential
analysis and was within normal limits. One-way repeated
measures analysis of variance (ANOVA) with Bonferroni-
adjusted post hoc t-tests were used to compare measure-
ments between each of the shoe conditions. Comparisons
were considered statistically significant if p < 0.05.
Results
Contact time (whole foot)
To cross check if participants walked at a consistent
speed during the trials, differences in whole foot contact
time based on the pedar data were evaluated between
the three shoe conditions (Table 2). Whilst regularity of
walking speed was ensured within ± 5% by the data col-
lection protocol, verification using pedar data was also
undertaken due to the important effect of walking speed
on peak plantar pressure [16]. No statistically significant
difference between contact times (i.e. walking speed) for
the whole foot (F2-12 = 2.350, p = 0.138) were found.
Therefore, it can be assumed that any differences inplantar pressures can be attributed to the conditions
being analysed.
Peak pressure differences (mask)
Tables 2 and 3 provide data related to peak pressure
changes according to shoe condition. A statistically sig-
nificant difference in peak plantar pressure was found
between shoes (F2-12 = 11.813, p = 0.001). The DH
Pressure-relief ShoeTM reduced peak plantar pressures by
117.7 kPa compared to the standard shoe and 160.5 kPa
compared to canvas shoe. This equates to a decrease in
peak pressure of 43% and 50% respectively. When com-
pared to the canvas shoe, which was included as the
‘control’ condition, the participant’s own shoes decreased
peak pressure by 42.9 kPa or 14% on average, although
this did not reach statistical significance.
Contact area (whole foot)
A statistically significant difference in contact area for
the whole foot was found between shoes (F2-12 = 5.360,
p = 0.022). Post hoc tests revealed that there was a sig-
nificant difference in whole foot contact area between
the DH Pressure-relief ShoeTM and canvas shoe (mean
difference of 10.8 cm2). This increase in contact area
equates to the plantar surface of the foot having a 9%
larger weight bearing area with the DH Pressure-relief
ShoeTM compared to the canvas shoe. There were no dif-
ferences between the DH Pressure-relief ShoeTM and the
standard shoe, or the canvas shoe and standard shoe.
Discussion
The aim of this study was to evaluate the capacity of the
DH Pressure Relief ShoeTM to offload high pressure areas
under the neuropathic foot in diabetes. The DH
Pressure-relief ShoeTM was selected for investigation in
this study as it is currently being marketed and used for
offloading plantar foot ulceration in diabetes. To the
authors’ knowledge, there has been no independent re-
search that has previously investigated the capacity of
the DH Pressure Relief ShoeTM to reduce pressure. In
contrast, the DH Pressure WalkerTM, Royce Medical (now
the Active Offloading WalkerTM, Ossur, CA) a related
product in a below-knee walker style, has been investi-
gated previously [18,19]. The DH Pressure Relief ShoeTM
is a less bulky version of the DH Pressure WalkerTM. It is
also light, easy to fit and use, and is cost effective at
around AUS $100 per unit. Of particular interest is the
insole design in the DH Pressure Relief ShoeTM, which
allows for customisation of offloading by the selective re-
moval of the hexagonal-shaped plugs over high pressure
sites. The DH Pressure Relief ShoeTM is designed as a re-
movable intervention and while in some clinical circum-
stances this might be preferable, research has shown
Table 2 Mean, standard deviation and standard error for contact time, peak pressure and contact area for each shoe
condition (N = 14)
Contact Time (m/s) (whole foot) Peak Pressure (kPa) (mask) Contact Area (cm2) (whole foot)
Mean SD Mean SD Mean SD
Canvas 684.5 101.5 315.9 140.7 116.8 20.5
Standard 672.9 88.5 273.0 127.1 124.9 31.7
DH shoe 699.3 96.9 155.4 89.9 127.6 26.7
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healing rates [18-20].
In this study the DH Pressure Relief ShoeTM was
shown to reduce mean peak plantar pressure by 117.7
kPa when compared to standard shoes and 160.5 kPa
when compared to canvas shoes. This equates to a 43%
and 50% reduction respectively, which is comparable in
magnitude to studies using specific types of padding
and insoles [21,22]. While there is no established pres-
sure cut-off point or threshold above which ulceration
will occur, a relationship has been shown to exist
whereby the greater the pressure the higher the ulcer
risk [11]. With this in mind, we believe that this
amount of pressure reduction is clinically important.
We powered our study to detect a 100 kPa reduction
(or difference between shoes) and the amount of reduc-
tion offered by the DH Pressure Relief ShoeTM was well
above this. Therefore, the removable plug design insole
that is integral to the DH Pressure Relief ShoeTM shows
promise for offloading focal plantar pressure. Accord-
ingly, this device may be useful for the treatment of
neuropathic ulcers, in the event that these results carry
over into trials that use healing as a primary outcome.
It is important to note that the investigators in this
project had some concerns about the fixation of the DH
shoe in its current form and the stability of some partici-
pants while walking. In two cases the ankle straps did
not sit flat, which may potentially cause rubbing and irri-
tation to the skin. In another case the medial heel coun-
ter was pushed down substantially during gait due to the
high degree of rigid foot deformity, rendering the shoe
too unstable to be worn during extended periods ofTable 3 Comparison between the shoe conditions for peak pr
Peak pressure (mask)
Mean difference in peak






42.9 (−35.6 to 121.3) 14% decrease 0
Canvas /
DH shoe
160.5 (60.1 to 261.0) 51% decrease 0
Standard /
DH shoe
117.7 (40.1 to 186.3) 43% decrease 0
# A decrease in the % indicates that the second shoe recorded a lower pressure tha
higher pressure than the first.walking. Suitability of this device as an offloading modal-
ity for some participants was questioned, particularly
when dealing with a sub-population known to be at risk
of falls. In addition, the aesthetics of the device may be a
limitation to its acceptance by some patients. Therefore,
the DH Pressure Relief ShoeTM may be a useful alterna-
tive to current off-loading modalities but further clin-
ical trials are warranted to determine its safety in
everyday activities and relative contraindications.
Several possible explanations exist as to why peak pres-
sures were substantially reduced by the DH Pressure Re-
lief ShoeTM. Due to the relatively thick and cushioning
make-up of the DH Pressure Relief ShoeTM insoles, it is
likely that the plantar surface of the foot sinks into the
materials to redistribute force. This, in combination with
the removal of the plugs over pressure sites, may explain
the levels of offloading recorded. We also found a statis-
tically significant difference in whole foot contact area
where the DH Pressure Relief ShoeTM had a 9% greater
contact area than the canvas shoe. However, this result
did not extend to differences in contact area between the
DH Pressure Relief ShoeTM and standard shoe.
Interestingly, peak pressure values in the patients’ own
shoes (i.e. the standard shoe condition) did not differ
statistically from the canvas control shoe. This finding is
consistent with the 2007 evidence-based guidelines of
the International Working Group on the Diabetic Foot,
which recommend that standard or therapeutic footwear
alone should not be used for offloading during ulcer
treatment as better modalities are available [7]. It should
be noted, however, that the participant’s own shoes were
included only to allow comparison of plantar pressuresessure and contact area (N = 14)
Contact area (whole foot)
value Mean difference in contact




.473 8.1 (−4.9 to 21.1) 7% increase 0.336
.002 10.8 (2.1 to 19.4) 9% increase 0.014
.001 2.7 (−9.1 to 14.5) 2% increase 1.000
n the first and an increase in the % indicates that the second shoe recorded a
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Shoe. It was not the intention of this study to evaluate
footwear as an alternative offloading device.
Our findings should be interpreted in light of the
study limitations. Firstly, we measured peak pressure,
not healing, as a primary outcome measure and results
cannot be directly extrapolated. Pertinent issues that ef-
fect healing, such as compliance, functional effectiveness
of the device and health-related quality of life, would not
be borne out by this study design. Secondly, the study
was not designed as a randomised controlled trial, it was
an initial exploration of the effects of the DH Pressure
Relief ShoeTM on plantar pressure. A larger, high-quality
randomised trial with a comparison group is now
needed to evaluate the effectiveness of the DH Pressure
Relief ShoeTM on ulcer healing. Finally, despite the pedar®
system being valid and reliable, it only measures forces
acting vertical to the pedar® insole and it is likely that
the forces that shoes exert against the plantar surface of
the foot are more complex in nature. As the pressure-
mapping insoles had to contour the inside of each shoe
condition tested, rather than lie flat, they only record re-
sultant force [23,24]. As such, the shear component of
such forces are not recorded and some inherent meas-
urement errors are likely to occur [23,24].
Conclusions
The DH Pressure-relief ShoeTM reduced peak plantar
pressure more than the other two shoe conditions
tested. Accordingly, it may be beneficial for the treat-
ment or prevention of neuropathic ulcers and may be a
useful alternative to current off-loading modalities used
for diabetic foot ulceration. Clinical trials are now
needed to establish the impact of the device on ulcer
healing and prevention, and to ensure they are useable
and safe for patients in everyday activities.
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